Pericarditis as a Secondary Complication of COVID-19 in a Renal Transplant Patient. WMJ 2021 Dec;120(4):313-315
Date
01/14/2022Pubmed ID
35025181Scopus ID
2-s2.0-85123461858 (requires institutional sign-in at Scopus site) 2 CitationsAbstract
INTRODUCTION: A wide range of complications from COVID-19 are being reported, including cardiac complications.
CASE PRESENTATION: A 71-year-old woman with systemic lupus erythematosus complicated by focal segmental glomerular sclerosis status post kidney transplant presented with worsening left-sided chest pain after receiving treatment for COVID-19 pneumonia at an outside hospital. She was subsequently diagnosed with acute pericarditis, likely secondary to viral infection with COVID-19, and was successfully treated with aspirin and colchicine for 90 days without complications.
DISCUSSION: NSAIDs and colchicine are mainstays in acute pericarditis treatment. Though treatment presented a potential challenge given this patient's prior kidney transplant, aspirin and colchicine proved to be effective in treating her case of COVID-19-associated pericarditis.
CONCLUSION: This report has implications for future treatment of renal transplant patients with COVID-19-related pericarditis and emphasizes the need for research into the pathophysiology of pericarditis in the context of COVID-19, including risk factors and treatment.
Author List
Brockman T, Hernandez L, Mehta T, Thapa BAuthor
Bipin Thapa MD Assistant Dean, Professor in the Medicine department at Medical College of WisconsinMESH terms used to index this publication - Major topics in bold
AgedColchicine
Female
Humans
Kidney Transplantation
Pericarditis
